PRESS-RELEASE ·Filed Apr 20, 2026
Press release · FDA
Actionable Insight • Neutral
Monitor for scientific interest or potential partnerships stemming from the presented data, but expect limited immediate market reaction.
Final — all horizons settled through T+60d ⚠ clustered
AAPG ▼ -26.94% at T+60d
NEUTRAL call -26.94% · α vs SPY -32.51% · entry $25.65 → $18.74
T+1d
-2.03%
call -2.03% · α -3.04%
$25.13
settled 6mo ago
T+5d
-10.33%
call -10.33% · α -11.41%
$23.00
settled 6mo ago
T+20d
-25.96%
call -25.96% · α -30.18%
$18.99
settled 5mo ago
T+60d
-26.94%
call -26.94% · α -32.51%
$18.74
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Ascentage Pharma announced it will present four preclinical studies at the AACR 2026 Annual Meeting. This is a routine scientific disclosure with no immediate commercial or regulatory implications.
Key Facts
- Ascentage Pharma will present four preclinical studies at AACR 2026 Annual Meeting
- Event dates: April 17–22, 2026 in San Diego, CA
- No new clinical data, regulatory decisions, or financial updates were disclosed
Financial Impact
Minimal near-term financial impact — preclinical data presentations typically do not drive revenue or valuation changes
Risk Factors
- Preclinical results may not translate to clinical success
- No disclosed timelines for clinical development or regulatory filings
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3276678 |
29 reports for AAPG
67% Hit rate @ T+1 Went positive at some point 5 of 6 best @ T+20▲ +13.03%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 6-K | $14.92 | awaiting T+1 | — | $15.61 (+4.66%) |
Oct 21, 2026 4d ago | 6-K | $14.92 $15.44 | ▲ +3.49% | ▲ +4.01% | $15.61 (+4.66%) |
Oct 15, 2026 11d ago | 6-K | $14.69 $15.37 | ▲ +4.63% | ▲ +5.74% | $15.61 (+6.30%) |
Sep 17, 2026 5w ago | 6-K | $15.37 $15.06 | ▲ +2.02% | ▲ +1.90% | $15.61 (−1.59%) |
Aug 19, 2026 9w ago | Press Release | $17.32 $17.00 | ▲ +1.85% | ▲ +2.26% | $15.61 (+9.84%) |
Aug 5, 2026 11w ago | 6-K | $16.86 $17.09 | ▲ +1.39% | ▲ +1.55% | $15.61 (−7.36%) |
Aug 3, 2026 12w ago | 6-K | $16.81 $16.69 | ▼ −0.68% | ▼ −2.49% | $15.61 (−7.08%) |
Jul 26, 2026 13w ago | Press Release | $18.89 $18.29 | ▼ −3.20% | ▼ −3.44% | $15.61 (−17.34%) |
Jul 20, 2026 14w ago | 6-K | $18.37 $19.10 | ▲ +3.97% | ▲ +3.14% | $15.61 (−15.00%) |
Jul 13, 2026 14w ago | 6-K | $19.24 $20.18 | ▲ +4.89% | ▲ +4.49% | $15.61 (−18.84%) |
Showing 10 of 29
US Market Status
Market Open — Closes in 4h 4m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers